Search

everythinglearnresearchcommunity

for

Search:↓

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

A new compound was effective for imaging prostate cancer in rats.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Finasteride helps treat eyelid spasms.

Obesity is linked to more severe lower urinary tract symptoms.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Higher PSA levels are linked to more hirsutism in women with PCOS.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Higher DHT in male baldness may protect against prostate cancer.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Finasteride treats hair loss but may affect prostate cancer detection.

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Higher cholesterol levels increase aggressive prostate cancer risk.

The IPP index is linked to storage symptoms and leftover urine, and may help manage urinary tract symptoms.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.